Insider Transactions in Q4 2020 at Bio Atla, Inc. (BCAB)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2020
|
Guy Levy Director |
BUY
Open market or private purchase
|
Indirect |
1,388,890
+50.0%
|
$25,000,020
$18.0 P/Share
|
|
Dec 18
2020
|
Guy Levy Director |
BUY
Conversion of derivative security
|
Indirect |
1,790,472
+50.0%
|
-
|
|
Dec 18
2020
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
800,000
+25.87%
|
$14,400,000
$18.0 P/Share
|
|
Dec 18
2020
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
1,492,060
+50.0%
|
-
|
|
Dec 18
2020
|
Pfizer Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,238,090
+50.0%
|
-
|